Home > Journals > Italian Journal of Dermatology and Venereology > Past Issues > Italian Journal of Dermatology and Venereology 2021 February;156(1) > Italian Journal of Dermatology and Venereology 2021 February;156(1):13-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Italian Journal of Dermatology and Venereology 2021 February;156(1):13-9

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

The role of Smad7 in cutaneous wound healing

Min-Feng WU 1, Qing-Yu ZENG 2, Jian-Hua HUANG 1, Hong-Wei WANG 1

1 Department of Dermatology, Huadong Hospital, Fudan University, Shanghai, China; 2 Shanghai Skin Disease Hospital, Institute of Photomedicine, Tongji University School of Medicine, Shanghai, China


PDF


Chronic refractory wounds are generally caused by local tissue defects and necrosis, and they are characterized by delayed wound healing as well as high recurrence, which seriously affects life quality. However, effective therapeutics to treat wounds are currently unavailable. Therapy primarily aims to accelerate generation of granulation tissue and decrease recurrence. The pathogenesis of chronic refractory wounds is closely related to multiple complex signaling pathways and a series of cytokines. Among these signaling pathways, TGF-β/Smad7 axis plays a critical role. Specifically, Smad7 is an antagonist of TGF-β that inhibits activation of TGF-β. Moreover, Smad7 promotes wound healing by regulating cytokines and controlling growth, differentiation and apoptosis of cells, which may be exploited to cure the disease. This review aims to reveal the exact functions and mechanisms of Smad7 in regulation of wound healing.


KEY WORDS: Smad7 protein; Wound healing; Transforming growth factor beta; Etiology

top of page